BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy? by unknown
ORAL PRESENTATION Open Access
BACH2 represses effector programmes to
stabilize Treg-mediated immune homeostasis -
a new target in tumor immunotherapy?
Rahul Roychoudhuri1*, Kiyoshi Hirahara2, Kambiz Mousavi2, David Clever1, Michael Bonelli2, Christopher Klebanoff1,
Vittorio Sartorelli2, Yuka Kanno2, Luca Gattinoni1, Ena Wang3, Hui Liu3, Franco Marincola3, Igarashi Kazuhiko4,
John O’Shea2, Nicholas P Restifo1
From Society for Immunotherapy of Cancer 28th Annual Meeting
National Harbor, MD, USA. 8-10 November 2013
Through their functional diversification, distinct lineages of
CD4+ T cells play key roles in either driving or constraining
immune-mediated pathology and anti-tumor immune
responses. Transcription factors are critical in the genera-
tion of cellular diversity, and negative regulators antagonis-
tic to alternate fates often act in conjunction with positive
regulators to stabilize lineage commitment. Genetic poly-
morphisms within a single locus encoding the transcription
factor BACH2 are associated with numerous autoimmune
and allergic diseases including asthma, Crohn’s disease,
coeliac disease, vitiligo, multiple sclerosis and type 1
diabetes. While these associations point to a shared
mechanism underlying susceptibility to diverse immune-
mediated diseases, a function for Bach2 in the maintenance
of immune homeostasis had not been established. We have
found that Bach2 plays a broad role in maintaining immune
homeostasis, by stabilizing Treg-mediated immunoregula-
tory capacity while repressing the differentiation pro-
grammes of multiple effector lineages in CD4+ T cells.
Bach2 was required for efficient formation of regulatory
(Treg) cells and consequently for suppression of lethal
inflammation in a that was Treg cell dependent. Assess-
ment of the genome-wide function of Bach2, however,
revealed that it represses genes associated with effector cell
differentiation. Consequently, its absence during Tregpolar-
ization resulted in inappropriate diversion to effector
lineages. In addition, Bach2 constrained full effector differ-
entiation within Th1, Th2 and Th17 cell lineages. These
findings identify Bach2 as a key regulator of CD4+ T-cell
differentiation that regulates the systemic balance between
tolerance and immunity. These findings have implications
for the design of novel therapies aimed at disrupting
immune tolerance while promoting anti-tumor effector
responses.
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